What stock options related to EVLV are reported in this Form 4?

The Form 4 shows a stock option to buy 80,745 shares at an exercise price of $0.24, which was exercised on 11/17/2025. After this exercise, the reporting person held 1,462,229 derivative securities (stock options) directly.

Evolv (EVLV) director Form 4: sells 80,745 shares at $5.8

Q: What insider transaction did EVLV report in this Form 4?

The Form 4 reports that a director of Evolv Technologies Holdings, Inc. (EVLV) exercised stock options for 80,745 shares of Class A common stock at $0.24 per share and sold 80,745 shares at a weighted average price of $5.8 on 11/17/2025.

Q: Was the EVLV insider sale made under a Rule 10b5-1 trading plan?

Yes. The sales disclosed were made under a Rule 10b5-1 trading plan that the reporting person entered into on June 12, 2025, as noted in the explanation of responses.

Q: At what prices were the EVLV shares sold in this insider transaction?

The Form 4 discloses a weighted average sale price of $5.8 per share, with individual sale prices ranging from $5.69 to $5.99. The reporting person has undertaken to provide detailed trade breakdowns upon request.

Q: What is the insider’s relationship to Evolv Technologies Holdings, Inc. (EVLV)?

The reporting person is identified as a director of Evolv Technologies Holdings, Inc. and has filed this Form 4 as one reporting person.

Evolv Technologies Holdings, Inc. (EVLV) director reported an option exercise and share sale.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Evolv Technologies Holdings, Inc. (EVLV) director reported an option exercise and share sale. On 11/17/2025, the reporting person exercised stock options to acquire 80,745 shares of Class A common stock at $0.24 per share and then sold 80,745 shares at a weighted average price of $5.8, with individual trades ranging from $5.69 to $5.99. These transactions were made under a Rule 10b5-1 trading plan entered into on June 12, 2025. After the transactions, the reporting person directly beneficially owned 2,083,961 shares, with an additional 151,135 shares held indirectly through the Family Horizon Trust, and continued to hold 1,462,229 stock options.

Insider Trade Summary

Exercise and Sale: 80,745 shares ($449K approx. pre-tax spread)

Exercise and Sale 4 txns

Insider Ellenbogen Michael

Role Director

Sold 80,745 shs ($468K)

Approx. gross sale proceeds $468K

Approx. exercise cost $19K

Approx. pre-tax spread $449K

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy)	80,745	$0.00	$0.00
Exercise	Class A Common Stock	80,745	$0.24	$19K
Sale	Class A Common Stock	80,745	$5.80	$468K
holding	Class A Common Stock	--	--	--

Holdings After Transaction: Stock Option (Right to Buy) — 1,462,229 contracts (Direct); Class A Common Stock — 2,083,961 shares (Direct); Class A Common Stock — 151,135 shares (Indirect, Held by Family Horizon Trust)

Footnotes (3)

F1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on June 12, 2025.
F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.69 to $5.99. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3. The option vested and became exercisable as to 25% on January 31, 2018 and vested in 36 equal monthly installments thereafter.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did EVLV report in this Form 4?

The Form 4 reports that a director of Evolv Technologies Holdings, Inc. (EVLV) exercised stock options for 80,745 shares of Class A common stock at $0.24 per share and sold 80,745 shares at a weighted average price of $5.8 on 11/17/2025.

Was the EVLV insider sale made under a Rule 10b5-1 trading plan?

Yes. The sales disclosed were made under a Rule 10b5-1 trading plan that the reporting person entered into on June 12, 2025, as noted in the explanation of responses.

How many EVLV shares does the insider own after the reported transactions?

Following the reported transactions, the reporting person beneficially owned 2,083,961 shares of EVLV Class A common stock directly and 151,135 shares indirectly through the Family Horizon Trust.

At what prices were the EVLV shares sold in this insider transaction?

The Form 4 discloses a weighted average sale price of $5.8 per share, with individual sale prices ranging from $5.69 to $5.99. The reporting person has undertaken to provide detailed trade breakdowns upon request.

What is the insider’s relationship to Evolv Technologies Holdings, Inc. (EVLV)?

The reporting person is identified as a director of Evolv Technologies Holdings, Inc. and has filed this Form 4 as one reporting person.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 11/18/2025 - 04:02 PM EST

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ellenbogen Michael

(Last)

(First)

(Middle)

C/O EVOLV TECHNOLOGIES, INC.

500 TOTTEN POND ROAD, 4TH FLOOR

(Street)

WALTHAM

02451

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Evolv Technologies Holdings, Inc. [ EVLV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A Common Stock	11/17/2025		M		80,745	A	$0.24	2,164,706	D
Class A Common Stock	11/17/2025		S⁽¹⁾		80,745	D	$5.8⁽²⁾	2,083,961	D
Class A Common Stock								151,135	I	Held by Family Horizon Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (Right to Buy)	$0.24	11/17/2025		M			80,745	⁽³⁾	09/13/2027	Class A Common Stock	80,745	$0	1,462,229	D

Explanation of Responses:

1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on June 12, 2025.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.69 to $5.99. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. The option vested and became exercisable as to 25% on January 31, 2018 and vested in 36 equal monthly installments thereafter.

Remarks:

	/s/ Rachel Roy, Attorney-in-fact for Michael Ellenbogen	11/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR